Hematologist Amir Toor, MD, joined Lehigh Valley Topper Cancer Institute in March 2023. He’s started building the program and educating staff members on the intricacies of these specialized treatments.
“It is an honor to bring stem cell transplantation and cellular therapies to adults in the Lehigh Valley and its surrounding communities,” Dr. Toor says. “These state-of-the-art treatments are lifesaving for many patients with hematologic malignancies, but they are also physically and mentally taxing. Being able to receive these therapies close to home is an absolute advantage for these patients.”
Dr. Toor has more than 20 years of experience with autologous and allogeneic transplants. He also has expertise with cellular therapies for hematologic malignancies, specifically chimeric antigen receptor (CAR) T-cell therapy. He has published extensively on the immunobiology and application of hematopoietic cell transplantation, with nearly 200 scientific abstracts and peer-reviewed publications over the span of his career. His particular interest is in transplantation for multiple myeloma, lymphoma, myelodysplastic syndrome, acute leukemia and myeloproliferative neoplasms.
“Dr. Toor is a renowned transplanter, and he is dedicated to determining the best treatment option for each individual based on their comorbidities and the genomics of their malignancy,” says hematologist oncologist Suresh Nair, MD, Physician in Chief, Lehigh Valley Topper Cancer Institute. “He is also heavily involved in researching novel cellular therapies that could lead to better outcomes and quality of life for patients in the near future, and his work in this area will be a major asset to our program.”
The Cancer Institute’s membership in the Memorial Sloan Kettering Cancer Alliance will also connect the new program to additional stem cell transplant and cellular therapy education and resources.